Literature DB >> 11792968

The effect of vascular endothelial growth factor on a rat model of traumatic arteriogenic erectile dysfunction.

Ming-Chan Lee1, Ahmed I El-Sakka, Tulio M Graziottin, Hao-Chung Ho, Ching-Shwun Lin, Tom F Lue.   

Abstract

PURPOSE: We tested the hypothesis that intracavernous injection of vascular endothelial growth factor (VEGF) can restore erectile function in a rat model of traumatic arteriogenic erectile dysfunction.
MATERIALS AND METHODS: Exploration of bilateral internal iliac arteries was performed in 50, 3-month-old male rats. A total of 44 rats underwent bilateral ligation of the internal iliac arteries and 6 that underwent exploration only served as the sham operated group. Minutes later intracavernous injection of phosphate buffered saline (PBS) plus bovine serum albumin in 16 rats, 2 microg. VEGF plus PBS plus BSA in 12 and 4 microg. VEGF plus PBS plus BSA in 16 was performed. At weeks 1, 2 and 6 about a third of the rats in each group underwent electrostimulation of the cavernous nerves to assess erectile function and were then sacrificed. Penile tissues were collected for histochemical and electron microscopy examinations.
RESULTS: No impairment of erectile function was noted in sham operated rats. Immediately after arterial ligation all rats showed little or no erectile response to neurostimulation. In PBS treated rats modest recovery of erectile function was noted at week 6. Significant recovery of erectile function was noted in VEGF treated rats at weeks 1 and 2 in the 4 microg. group only and at week 6 in the 2 and 4 microg. groups. Neuronal nitric oxide synthase staining showed a reduction in neuronal nitric oxide synthase positive nerve fibers in the dorsal or intracavernous nerves at week 1. Moderate recovery of neuronal nitric oxide synthase positive nerve fibers was noted in the 2 and 4microg. VEGF treated groups but not in the PBS treated group. Electron microscopy revealed no pathological change in sham operated rats. In dorsal nerves the atrophy of myelinated and nonmyelinated nerve fibers was noted in ligated plus PBS treated rats. Partial recovery was observed in VEGF treated rats. Scattered atrophic smooth muscle cells were seen in PBS and occasionally in VEGF treated rats but not in the sham operated group. The most dramatic findings in VEGF treated rats were hypertrophy and hyperplasia of the endothelial cells, especially those lining the small capillaries.
CONCLUSIONS: Ligation of bilateral internal iliac arteries produced a reliable animal model of traumatic arteriogenic erectile dysfunction. Intracavernous injection of VEGF minutes after arterial ligation facilitated the recovery of erectile function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11792968     DOI: 10.1097/00005392-200202000-00080

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  21 in total

Review 1.  Therapy of erectile dysfunction: potential future treatments.

Authors:  Nestor F Gonzalez-Cadavid; Jacob Rajfer
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.633

Review 2.  Three important components in the regeneration of the cavernous nerve: brain-derived neurotrophic factor, vascular endothelial growth factor and the JAK/STAT signaling pathway.

Authors:  Hai-Yang Zhang; Xun-Bo Jin; Tom F Lue
Journal:  Asian J Androl       Date:  2010-12-20       Impact factor: 3.285

3.  Neuroregenerative strategies after radical prostatectomy.

Authors:  Robert C Dean; Tom F Lue
Journal:  Rev Urol       Date:  2005

4.  Transplantation of endothelial progenitor cells transfected with VEGF165 to restore erectile function in diabetic rats.

Authors:  Xin Gou; Wei-Yang He; Ming-Zhao Xiao; Ming Qiu; Ming Wang; Yuan-Zhong Deng; Chao-Dong Liu; Zao-Bing Tang; Jie Li; Yong Chen
Journal:  Asian J Androl       Date:  2010-11-29       Impact factor: 3.285

5.  Effects of low-energy shockwave therapy on the erectile function and tissue of a diabetic rat model.

Authors:  Xuefeng Qiu; Guiting Lin; Zhongcheng Xin; Ludovic Ferretti; Haiyang Zhang; Tom F Lue; Ching-Shwun Lin
Journal:  J Sex Med       Date:  2012-12-17       Impact factor: 3.802

Review 6.  Erectile dysfunction following radical retropubic prostatectomy: epidemiology, pathophysiology and pharmacological management.

Authors:  Kalyana C Nandipati; Rupesh Raina; Ashok Agarwal; Craig D Zippe
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

7.  Optimizing postoperative sexual function after radical prostatectomy.

Authors:  Manuela Tutolo; Alberto Briganti; Nazareno Suardi; Andrea Gallina; Firas Abdollah; Umberto Capitanio; Marco Bianchi; Niccolò Passoni; Alessandro Nini; Nicola Fossati; Patrizio Rigatti; Francesco Montorsi
Journal:  Ther Adv Urol       Date:  2012-12

8.  Does regular consumption of green tea influence expression of vascular endothelial growth factor and its receptor in aged rat erectile tissue? Possible implications for vasculogenic erectile dysfunction progression.

Authors:  D Neves; M Assunção; F Marques; J P Andrade; H Almeida
Journal:  Age (Dordr)       Date:  2008-04-18

Review 9.  Posttranslational modification of constitutive nitric oxide synthase in the penis.

Authors:  Biljana Musicki; Ashley E Ross; Hunter C Champion; Arthur L Burnett; Trinity J Bivalacqua
Journal:  J Androl       Date:  2009-04-02

Review 10.  What is the current role of intracavernosal injection in management of erectile dysfunction?

Authors:  A I El-Sakka
Journal:  Int J Impot Res       Date:  2016-04-14       Impact factor: 2.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.